Cravath’s New York Office Moves to Two Manhattan West
July 29, 2015
Cravath represented JPMorgan Chase Bank, N.A. as arranger of a $5 billion bridge commitment and a $1 billion revolving credit facility to support Celgene Corporation’s acquisition of Receptos, Inc. Celgene Corporation is a global biopharmaceutical company with a primary focus in developing therapies to treat cancer and inflammatory diseases. The transaction closed on July 29, 2015.
The Cravath team included partners James D. Cooper and Stephen L. Burns, senior attorney Patrick J. Moriarty and associates Jacob B. Ornstein and Saarah Woodby on banking and securities matters; and partner David J. Kappos and senior attorney Anthony N. Magistrale on intellectual property matters. Summer associate Stephanie M. Park also worked on banking matters.
Deals & Cases
March 29, 2024
Cravath represented the administrative agent, joint lead arrangers and joint bookrunners in connection with a £1.35 billion bridge facility made available to fund the proposed acquisition of Spirent Communications by Keysight Technologies, Inc., outbidding a previous proposal by Viavi Solutions. Keysight Technologies, Inc. is a global innovator in the computing, communications and electronics market. The transaction announced on March 28, 2024.
Deals & Cases
November 27, 2023
Cravath represented the administrative agent, joint lead arranger and joint bookrunner in connection with $14 billion of credit facilities made available to RTX Corporation, an aerospace and defense company that provides systems and services for commercial, military, and government customers worldwide. The facilities consisted of a $10 billion bridge credit facility and a $4 billion term loan facility. The transactions closed on October 24, 2023 and November 7, 2023.
Deals & Cases
October 06, 2023
Cravath represented the administrative agent, joint lead arranger and joint bookrunner in connection with $2.4 billion of credit facilities made available to Cencora, Inc., a leading global pharmaceutical solutions organization committed to improving patient access to products and enhance patient care. The facilities consisted of a $355 million tranche one revolving credit facility and a $2.045 billion tranche two revolving credit facility. The transaction closed on October 6, 2023.
Deals & Cases
August 31, 2023
Cravath represented the administrative agent, joint lead arranger and joint bookrunner in connection with a $1.3 billion term loan facility made available to Broadridge Financial Solutions, Inc., a leading provider of investor communications, technology‑driven solutions and data and analytics to the financial services industry. The transaction closed on August 17, 2023.
Celebrating 200 years of partnership. In 2019, we celebrated our bicentennial. Our history mirrors that of our nation. Integral to our story is our culture.
Attorney Advertising. ©2024 Cravath, Swaine & Moore LLP.